CMA Resurrects Claims Against Pfizer And Flynn On Phenytoin

UK Competition Regulator Once Again Alleges Pricing Abused Dominant Position

 
• By Dave Wallace
  
Phoenix bird flames wings space
The CMA’s claims against Pfizer and Flynn have been resurrected • Source: Alamy

More from Legal & IP

More from Generics Bulletin